Trials / Recruiting
RecruitingNCT07205991
ADHERE Trial: Strategies to Improve Mobile App Adherence
Assisting Digital HEalth REtention (ADHERE Trial): Protocol for a Study Within a Trial (SWAT)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 258 (estimated)
- Sponsor
- Neuroscience Research Australia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effectiveness of two communication interventions, compared to standard app notifications, in increasing adherence to a mobile health app among individuals with chronic low back pain. The main question it aims to answer is: Do phone calls or text messages increase adherence compared to app notifications in patients receiving a digital health intervention for chronic back pain? Participants will: A) Receive pain education and clinical hypnosis via a mobile app for managing chronic LBP; B) Will be contacted up to twice via phone call or text message, or they will only receive standard notifications from the app.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Phone calls | Participants will receive standard app notifications and be contacted for adherence via two phone calls, a week apart, if they fail to engage with the intervention for more than three consecutive days. The purpose of these calls will be to assess whether participants are experiencing any difficulties using the app or completing the sessions. |
| BEHAVIORAL | Text messages | Participants will receive the standard app notifications and receive a maximum of 2 text messages (SMS) a week apart, if they fail to engage with the intervention for more than three consecutive days. |
| BEHAVIORAL | App notifications | Participants will receive the standard app notifications . |
Timeline
- Start date
- 2025-10-30
- Primary completion
- 2027-05-26
- Completion
- 2028-05-26
- First posted
- 2025-10-03
- Last updated
- 2026-01-14
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT07205991. Inclusion in this directory is not an endorsement.